Honolulu Star-Advertiser

Monday, April 14, 2025 79° Today's Paper


Hawaii News

Cardax revenue sinks 47% in first quarter

CRAIG T. KOJIMA / 2015

David Watumull, CEO of tech company, Cardax Pharmaceuticals Inc., in his laboratory. Cardax Inc.’s revenue plunged 47.3% in the first quarter as the health store chain selling its anti-inflammatory product ZanthoSyn worked through existing inventory and ramped up promotions.